However, in pre‐clinical mouse models, the induction of MOMP in a fraction of caspase‐deficient tumours following radiotherapy resulted in pronounced tumour rejection dependent on cDC1‐CD8+ T cell action [100]. The gene discussed is CD8A; the disease is neoplasm.